Compare KIDS & BGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KIDS | BGY |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 588.8M | 530.1M |
| IPO Year | 2016 | N/A |
| Metric | KIDS | BGY |
|---|---|---|
| Price | $21.97 | $5.45 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.22 | N/A |
| AVG Volume (30 Days) | 170.1K | ★ 281.0K |
| Earning Date | 10-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.41% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,049,000.00 | N/A |
| Revenue This Year | $12.96 | N/A |
| Revenue Next Year | $11.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.95 | N/A |
| 52 Week Low | $14.42 | $5.19 |
| 52 Week High | $26.74 | $6.23 |
| Indicator | KIDS | BGY |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 31.55 |
| Support Level | $21.13 | $5.19 |
| Resistance Level | $23.31 | $5.86 |
| Average True Range (ATR) | 0.76 | 0.08 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 41.98 | 5.88 |
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
Blackrock Enhanced International Dividend Trust is a diversified closed-end management investment company. Its primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust invests the majority of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, with a key focus on securities of large capitalization companies. It invests directly in such securities or synthetically through the use of derivatives.